AI-driven gene therapy idea wins EQT Impact Challenge 2026

In partnership with: EQT The grand finale of EQT Impact Challenge 2026 at Hong Kong’s M+ Museum in September saw some of Asia’s most promising deep-tech founders tackling challenges across climate and health. The initiative, backed by global investment firm EQT and its philanthropic arm EQT Foundation, provides young companies with crucial early-stage investment alongside access to a global network of industry experts, investors and mentors. After a seven-month journey that attracted more than 200 applicants and almost 6,000 public votes, five finalists took to the stage. Advent Gene Therape